| J3380 | Injection, vedolizumab, intravenous, 1 mg | 21,600 | $20 | $367.2K |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 7,630 | $40 | $289.9K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 5,680 | $30 | $192.9K |
| J0897 | Injection, denosumab, 1 mg | 7,200 | $20 | $129.6K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,090 | $30 | $77.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 380 | $90 | $33.4K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 370 | $50 | $17.6K |
| 95250 | In this procedure, interstitial glucose levels are measured at regular intervals via subcutaneously implanted sensors provided by physician or other qualified health care professional's office for a… | 90 | $110 | $10.4K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 50 | $120 | $5.9K |
| 96366 | The provider administers an intravenous infusion or infusions of a medication for an additional hour or subsequent hours after the first hour to prevent, treat, or diagnose a condition or disease. | 200 | $20 | $3.3K |